Difference between revisions of "ALK translocation renal cell carcinoma"

ALK translocation renal cell carcinoma (view source)

559 bytes removed , 14:06, 4 April 2019

48,830

edits

@@ Line 11: / Line 11: @@
 DDx:
-*[[Papillary renal cell carcinoma]].<ref name=pmid29685646>{{Cite journal  | last1 = Pal | first1 = SK. | last2 = Bergerot | first2 = P. | last3 = Dizman | first3 = N. | last4 = Bergerot | first4 = C. | last5 = Adashek | first5 = J. | last6 = Madison | first6 = R. | last7 = Chung | first7 = JH. | last8 = Ali | first8 = SM. | last9 = Jones | first9 = JO. | title = Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma. | journal = Eur Urol | volume = 74 | issue = 1 | pages = 124-128 | month = 07 | year = 2018 | doi = 10.1016/j.eururo.2018.03.032 | PMID = 29685646 }}</ref> - especially "type 2".<ref name=pmid24255633/>
+*[[Papillary renal cell carcinoma]] - especially "type 2".<ref name=pmid24255633/>
 *[[Unclassified renal cell carcinoma]]
 *[[Renal medullary carcinoma]].